Korro Bio is trading at $12.08 (up 5%) as the stock stages a relief bounce following a sharp 6.1% drop on July 20 and a week of broader declines.

  • The move appears driven primarily by technical buying and a relief rally, as there are no new company-specific headlines, SEC filings, or earnings releases to account for the price action.
  • The stock's recovery comes even as the biotech sector (XBI) trades lower, though broader market indices are showing moderate gains.